Fig. 4

A10-FMT improved testicular metabolism. a Testicular docosahexaenoic acid (DHA) levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. b Testicular 9-hydroxy-2Z,5E,7Z,11Z,14Z-Eicosapentaenoic acid levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. c Testicular 4-oxo-Retinoic acid levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. d Testicular protein levels of PLZF and DAZL in different treatments determined by Western blotting. e Testicular testosterone isocaproate levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. f Testicular testosterone glucuronide levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. g Testicular stenbolone levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. h Testicular cortisol 21-acetate levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. i Testicular PC (16:0/5:1(4E)) levels in different treatments. The y-axis represents the relative amount. The x-axis represents the treatment. *p < 0.05. n = 10/group